Data / Form D filings / Pivot Pharmaceuticals Inc.
Pivot Pharmaceuticals Inc.: Form D filing
Pivot Pharmaceuticals Inc., a pharmaceuticals company in Vancouver, British Columbia, Canada, filed a Form D with the SEC in 2015. The latest, on December 8, 2015, reports $4.2 million sold of a $4.2 million offering to 9 investors.
Find out what Pivot Pharmaceuticals Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1275 WEST 6TH AVENUE, SUITE 300, Vancouver, British Columbia, Canada, V6H 1
- Phone
- (604) 805-7783
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- British Columbia, Canada
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 505, Rule 506(b), Securities Act section 4(a)(5)
- SEC identifier (CIK)
- 1464165
The full lists. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 8, 2015 | New notice | $4,227,500 | $4,227,500 | $0 | 9 | Nov 20, 2015 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Pravin Chaturvedi | Executive Officer, Director | |
| Moira Ong | Executive Officer | |
| Patrick Frankham | Director | |
| Ahmad Doroudian | Director | |
| Wolfgang Renz | Director |
Every Form D from the week of Dec 7, 2015 · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Pivot Pharmaceuticals Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.